# Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

> **NCT00381472** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 393 (—)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Ropinirole

## Key facts

- **NCT ID:** NCT00381472
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 393 (—)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00381472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00381472, "Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00381472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*